Bryan Giraudo's Net Worth
$305 Thousand
Who is Bryan Giraudo?
Bryan Giraudo does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Gossamer Bio, Inc., and Protagonist Therapeutics, Inc.
SEC CIK
Bryan Giraudo's CIK is 0001740847
Past Insider Trading and Trends
2023 was Bryan Giraudo's most active year for acquiring shares with 13 total transactions. Bryan Giraudo's most active month to acquire stocks was the month of April. 2023 was Bryan Giraudo's most active year for disposing of shares, totalling 5 transactions. Bryan Giraudo's most active month to dispose stocks was the month of April. 2023 saw Bryan Giraudo paying a total of $317,414.03 for 1,276,276 shares, this is the most they've acquired in one year. In 2022 Bryan Giraudo cashed out on 10,722 shares for a total of $95,586.63, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gossamer Bio, Inc. (GOSS) Snapshot price: $0.865
COO/CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.48% | -6.43K |
$1.16 | -$7,430.51 | 92.74K |
Mar 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 4
| +111.10% | 200K |
$0.56 | $112,880.00 | 380.01K |
Nov 13
| |||
Form 4
| +42.88% | 54.02K |
$1.82 | $98,316.40 | 180.01K |
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
| +77.48% | 55K |
$1.02 | $56,094.50 | 125.99K |
Apr 4
| |||
Form 4
| +238.21% | 50K |
$0.97 | $48,435.00 | 70.99K |
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
| +194.76% | 13.87K |
$7.21 | $99,995.49 | 20.99K |
Jul 15
| |||
Form 4
| -9.76% | -10.72K |
$8.91 | -$95,586.63 | 99.17K |
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
| -4.76% | -5.49K |
$9.48 | -$52,045.75 | 109.89K |
Mar 23
| |||
Form 4
| +63.94% | 45K |
—
|
—
| 115.38K |
Feb 25
| |||
Form 4
| +72.80% | 3K |
$10.01 | $30,036.00 | 7.12K |
Oct 14
| |||
Form 4
| +94.30% | 2K |
$12.96 | $25,922.40 | 4.12K |
Jun 23
| |||
Form 4
| +194.73% | 46.5K |
—
|
—
| 70.38K |
Feb 14
| |||
Form 4
| +112.10% | 1.12K |
$16.78 | $18,810.16 | 2.12K |
Sep 26
| |||
Form 4
|
∞
| 1K |
$18.70 | $18,700.00 | 1K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
∞
| 23.88K |
$16.00 |
—
| 23.88K |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $25.46
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
∞
| 8K |
$5.70 | $45,620.00 | 8K |
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
∞
| 10K |
$6.46 | $64,566.00 | 10K |
May 16 - May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||